Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in Classical Homocystinuria
NCT04015557Phase 2Suspended
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Feb 2022
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in homocystinuria (HCU), sponsored by Hospital de Clínicas de Porto Alegre. Started Feb 2022; status: suspended.
02
Drugs
acetylcysteine
03
Conditions
homocystinuria (HCU)
Beyond the preview
Go deeper on NCT04015557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04015557.